Discover a study that suggest efruxifermin may offer delayed therapeutic benefits for patients with MASH-related cirrhosis.

New review debunks ten myths about catatonia, highlighting the need for validated screening tools and earlier clinical ...

The UKHSA has released its annual STI data, with continuing concern over rising syphilis and drug-resistant gonorrhoea. Learn ...